Evidence map›Paper›PMID 41769415›Full record

ReviewNeuro-oncology advances2026

Single-cell advances in the investigation of the pathogenesis and treatment of brain metastasis.

Robert S Porter, Clara Alves-Pereira, Priscilla K Brastianos

Abstract readReview
In one paragraph

Review in Neuro-oncology advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Robert S PorterDepartment of Neurology, Mass General Brigham, Boston, MA, USA.
Clara Alves-PereiraKrantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
Priscilla K BrastianosKrantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.ORCID https://orcid.org/0000-0003-4470-8425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain metastasis remains a significant cause of morbidity and mortality for cancer patients with limited treatment options. Single-cell RNA-seq has greatly expanded our ability to study cancer and metastasis, particularly in our assessment of tumor heterogeneity and the tumor microenvironment. In recent years, there have been several single-cell studies that have applied this technology to brain metastasis. These studies have described transcriptional characteristics of brain metastatic tumor cells and characterized immune cell changes as well as contributions of vascular and stromal cells to the brain metastatic microenvironment. This review article summarizes these studies, how they contribute to our knowledge of the molecular and cellular steps that occur in brain metastasis and in response to therapy, and how they suggest promise for future treatments.

Indexed as

brain metastasisorganotropismsingle-cell sequencing

Identifiers

PMID41769415
PMCPMC12946766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.